Argentina In Vitro Diagnostics Market Outlook

Argentina In Vitro Diagnostics Market Outlook to 2018- Clinical
Chemistry Genetic Testing, Haematology, Histology and
Cytology, Immuno Chemistry, Infectious Immunology and
Microbiology Culture
Report Details:
Published:November 2012
No. of Pages: 254
Price: Single User License – US$2500

Argentina In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing,
Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and
Microbiology Culture

Summary

GlobalData’s new report, “Argentina In Vitro Diagnostics Market Outlook to 2018- Clinical
Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious
Immunology and Microbiology Culture” provides key market data on the Argentina In Vitro
Diagnostics market. The report provides value (USD million) data for each segment and sub-
segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology,
Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The
report also provides company shares and distribution shares data for each of the aforementioned
market categories. The report is supplemented with global corporate-level profiles of the key
market participants with information on company financials and pipeline products, wherever
available.

This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics market categories – Clinical
Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious
Immunology and Microbiology Culture.
- Annualized market revenues (USD million) data for each of the segments and sub-segments

within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the Argentina In Vitro
Diagnosticsmarket.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott
Laboratories, Ortho-Clinical Diagnostics Inc., Beckman Coulter, Inc., Alere Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Argentina In Vitro
Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.

Get your copy of this report @
http://www.reportsnreports.com/reports/210648-argentina-in-vitro-diagnostics-market-outlook-to-2018-clinical-
chemistry-genetic-testing-haematology-histology-and-cytology-immuno-chemistry-infectious-immunology-and-
microbiology-culture.html

Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 15
2.1 What is This Report About? 15
3 In Vitro Diagnostics In Argentina 16
3.1 In Vitro Diagnostics, Market Segmentation 16
3.2 In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Constant, 2004-2018 17
3.3 In Vitro Diagnostics Market, Argentina, Revenue Mix ($m), 2011 19
3.4 In Vitro Diagnostics Market, Argentina, Category Contribution (%), 2011 20
3.5 In Vitro Diagnostics, Argentina, Company Share (2010-2011) 28
4 Clinical Chemistry In Argentina 30
4.1 Clinical Chemistry, Market Segmentation 30
4.2 Clinical Chemistry Market, Argentina, Revenue Mix ($m), 2011 31
4.3 Clinical Chemistry Market, Argentina, Segment Contribution (%), 2011 32
4.4 Clinical Chemistry Overall Revenue, (2004-2018) 33
4.4.1 Clinical Chemisty Analyzers, Revenue (2004-2018) 37
4.4.2 Urine Analysis, Revenue (2004-2018) 41

4.5 Clinical Chemistry Distribution Share (2010-2011) 45
4.6 Clinical Chemistry, Argentina, Company Share (2010-2011) 46
5 Genetic Testing In Argentina 48
5.1 Genetic Testing, Market Segmentation 48
5.2 Genetic Testing Market, Argentina, Revenue Mix ($m), 2011 49
5.3 Genetic Testing Market, Argentina, Segment Contribution (%), 2011 50
5.4 Genetic Testing Overall Revenue, (2004-2018) 51
5.5 Genetic Testing Distribution Share (2010-2011) 55
5.6 Genetic Testing, Argentina, Company Share (2010-2011) 56
6 Haematology In Argentina 58
6.1 Haematology Market, Market Segmentation 58
6.2 Haematology Market, Argentina, Revenue Mix ($m), 2011 59
6.3 Haematology Market, Argentina, Segment Contribution (%), 2011 60
6.4 Haematology Overall Revenue, (2004-2018) 61
6.4.1 Haematology Reagents, Revenue (2004-2018) 65
6.4.2 Immunohaematology, Revenue (2004-2018) 69
6.4.3 Haemostasis, Revenue (2004-2018) 73
6.4.4 Haematology Rapid Tests, Revenue (2004-2018) 77
6.4.5 Haematology Cell Counters, Revenue (2004-2018) 81
6.5 Haematology Distribution Share (2010-2011) 85
6.6 Haematology, Argentina, Company Share (2010-2011) 86
7 Histology And Cytology In Argentina 88
7.1 Histology and Cytology Market, Market Segmentation 88
7.2 Histology And Cytology Market, Argentina, Revenue Mix ($m), 2011 89
7.3 Histology And Cytology Market, Argentina, Segment Contribution (%), 2011 90
7.4 Histology And Cytology Overall Revenue, (2004-2018) 91
7.5 Histology And Cytology Distribution Share (2010-2011) 95
7.6 Histology And Cytology, Argentina, Company Share (2010-2011) 96
8 Immuno Chemistry In Argentina 98
8.1 Immuno Chemistry Market, Argentina, Revenue Mix ($m), 2011 98
8.2 Immuno Chemistry Market, Argentina, Segment Contribution (%), 2011 99
8.3 Immuno Chemistry Overall Revenue, (2004-2018) 101
8.3.1 Disease Specific Immunochemistry, Revenue, (2004-2018) 105
8.3.2 Drugs of Abuse / Toxicology, Revenue, (2004-2018) 109
8.3.3 Endocrinology Tests, Revenue, (2004-2018) 113
8.3.4 Immunochemistry Rapid Tests, Revenue (2004-2018) 117
8.3.5 Therapeutic Drug Monitoring, Revenue (2004-2018) 121
8.3.6 Immunochemistry Analyzers, Revenue (2004-2018) 125
8.4 Immuno Chemistry Distribution Share (2010-2011) 129
8.5 Immuno Chemistry, Argentina, Company Share (2010-2011) 130
9 Infectious Immunology In Argentina 132
9.1 Infectious Immunology, Market Segmentation 132

9.2 Infectious Immunology Market, Argentina, Revenue Mix ($m), 2011 133
9.3 Infectious Immunology Market, Argentina, Segment Contribution (%), 2011 134
9.4 Infectious Immunology Overall Revenue, (2004-2018) 135
9.4.1 Infectious Immunology Rapid Tests, Revenue (2004-2018) 139
9.5 Infectious Immunology Distribution Share (2010-2011) 143
9.6 Infectious Immunology, Argentina, Company Share (2010-2011) 144
10 Microbiology Culture In Argentina 146
10.1 Microbiology Culture, Market Segmentation 146
10.2 Microbiology Culture Market, Argentina, Revenue Mix ($m), 2011 147
10.3 Microbiology Culture Market, Argentina, Segment Contribution (%), 2011 148
10.4 Microbiology Culture Overall Revenue, (2004-2018) 149
10.4.1 Microbiology Analyzers, Revenue (2004-2018) 153
10.5 Microbiology Culture Distribution Share (2010-2011) 157
10.6 Microbiology Culture, Argentina, Company Share (2010-2011) 158
11 Overview of Key Companies in Argentina In Vitro Diagnostics Market 160
11.1 F. Hoffmann-La Roche Ltd. 160
11.1.1 Company Overview 160
11.1.2 Share in the Argentina In Vitro Diagnostics Market 160
11.2 Siemens Healthcare 161
11.3 Abbott Laboratories 162
11.4 Ortho-Clinical Diagnostics Inc. 163
11.5 Beckman Coulter, Inc. 164
11.6 Alere Inc. 165
11.7 bioMerieux S.A. 166
11.8 Bio-Rad Laboratories, Inc. 166
11.9 Sysmex Corporation 166
11.10 Becton, Dickinson and Company 167
11.11 DiaSorin S.p.A 167

11.12 Horiba, Ltd. 168
11.13 Mindray Medical International Limited 168
11.14 Thermo Fisher Scientific Inc. 169
11.15 Qiagen N.V. 169
11.16 PerkinElmer, Inc. 170
11.17 Gen-Probe Incorporated 170
11.18 Grifols, S.A. 171
11.19 Diagnostica Stago, Inc. 171
11.20 Life Technologies Corporation 172
11.21 Danaher Corporation 172
12 In Vitro Diagnostics Market Pipeline Products 173
12.1 Clinical Chemisty Market Pipeline Products 173
12.2 Immuno Chemistry Market Pipeline Products 176
12.3 Haematology Market Pipeline Products 187
12.4 Infectious Immunology Market Pipeline Products 189
12.5 Microbiology Culture Market Pipeline Products 196
12.6 Histology And Cytology Market Pipeline Products 197
12.7 Genetic Testing Market Pipeline Products 198
13 Financial Deals Landscape 203
13.1 Partnerships 203
13.1.1 bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 203
13.1.2 Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For
Archimedes Particle Metrology System 205
13.1.3 Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ 206
13.1.4 BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology
Assays 207
13.1.5 CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital
Microscopy Hematology Solutions 208
13.1.6 Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress
Dx Test 210
13.1.7 Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology

212
13.1.8 CML HealthCare Enters Into Agreement With MaRS Innovation 213
13.1.9 Castle Biosciences Enters Into Licensing Agreement With Brigham and Women''s Hospital
For Mesothelioma Test 214
13.1.10 Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein
Array Products 215
13.1.11 GeneCentric Diagnostics Enters Into Licensing Agreement With University of North
Carolina 216
13.1.12 Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB
Test 217
13.1.13 SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For
PhenoFluor 218
13.1.14 Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 219
13.1.15 MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test 220
13.1.16 NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
222
13.1.17 Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis 223
13.1.18 Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC
Test 224
13.1.19 One Lambda Enters Into Co-Marketing Agreement With CellTrend 225
13.1.20 Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For
ALK Cancer Biomarker 226
13.1.21 Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 227
13.1.22 Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
228
13.1.23 Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell
Technology 229
13.1.24 Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA 230
13.1.25 Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange
PCR Kit 231
13.1.26 Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 232
13.1.27 Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For
Pressure Cycling Technology 233
13.1.28 LipoScience Enters Into Licensing Agreement With Cleveland Clinic 234
13.1.29 GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact
Cyclotron And PET Tracer System 235
13.1.30 Sysmex Extends Distribution Agreement With Roche 236
13.1.31 NexDx Enters Into Licensing Agreement With University of California For Epigenetic
Biomarkers 237
13.1.32 Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 238
14 Appendix 240
14.1 Definitions of Markets Covered in the Report 241

14.1.1 In Vitro Diagnostics 241
14.2 Research Methodology 252
14.3 Secondary Research 252
14.4 Primary Research 252
14.5 Models 253
14.6 Forecasts 253
14.7 Expert Panels 253
14.8 GlobalData Consulting 254
14.9 Currency Conversion 254
14.10 Contact Us 254
14.11 Disclaimer 254

1.1 List of Tables
Table 1: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Constant, 2004-2018 18
Table 2: In Vitro Diagnostics Market, Argentina, Category Contribution (%), 2011 21
Table 3: In Vitro Diagnostics Market, Argentina, Cross-Category Analysis, 2004-2018 23
Table 4: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 25
Table 5: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 27
Table 6: In Vitro Diagnostics, Argentina, Company Share by Revenue ($m), USD Constant, 2010-
2011 29
Table 7: Clinical Chemistry Market, Argentina, Segment Contribution (%), 2011 32
Table 8: Clinical Chemistry, Argentina, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 34
Table 9: Clinical Chemistry, Argentina, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 36
Table 10: Clinical Chemisty Analyzers, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 38
Table 11: Clinical Chemisty Analyzers, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 40
Table 12: Urine Analysis, Argentina, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 42
Table 13: Urine Analysis, Argentina, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 44
Table 14: Clinical Chemistry, Argentina, Distribution Share by Revenue ($m), USD Constant,
2010-2011 45
Table 15: Clinical Chemistry, Argentina, Company Share by Revenue ($m), USD Constant, 2010-
2011 47
Table 16: Genetic Testing Market, Argentina, Segment Contribution (%), 2011 50
Table 17: Genetic Testing, Argentina, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 52

Table 18: Genetic Testing, Argentina, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 54
Table 19: Genetic Testing, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 55
Table 20: Genetic Testing, Argentina, Company Share by Revenue ($m), USD Constant, 2010-
2011 57
Table 21: Haematology Market, Argentina, Segment Contribution (%), 2011 60
Table 22: Haematology, Argentina, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 62
Table 23: Haematology, Argentina, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 64
Table 24: Haematology Reagents, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 66
Table 25: Haematology Reagents, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 68
Table 26: Immunohaematology, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 70
Table 27: Immunohaematology, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 72
Table 28: Haemostasis, Argentina, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 74
Table 29: Haemostasis, Argentina, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 76
Table 30: Haematology Rapid Tests, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 78
Table 31: Haematology Rapid Tests, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 80
Table 32: Haematology Cell Counters, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 82
Table 33: Haematology Cell Counters, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 84
Table 34: Haematology, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 85
Table 35: Haematology, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011
87
Table 36: Histology And Cytology Market, Argentina, Segment Contribution (%), 2011 90
Table 37: Histology And Cytology, Argentina, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 92
Table 38: Histology And Cytology, Argentina, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 94
Table 39: Histology And Cytology, Argentina, Distribution Share by Revenue ($m), USD Constant,
2010-2011 95

Table 40: Histology And Cytology, Argentina, Company Share by Revenue ($m), USD Constant,
2010-2011 97
Table 41: Immuno Chemistry Market, Argentina, Segment Contribution (%), 2011 100
Table 42: Immuno Chemistry, Argentina, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 102
Table 43: Immuno Chemistry, Argentina, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 104
Table 44: Disease Specific Immunochemistry, Argentina, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 106
Table 45: Disease Specific Immunochemistry, Argentina, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 108
Table 46: Drugs of Abuse / Toxicology, Argentina, Revenue ($m) USD Constant, by Sub-
Table 47: Drugs of Abuse / Toxicology, Argentina, Revenue ($m) USD Constant, by Sub-
Table 48: Endocrinology Tests, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 114
Table 49: Endocrinology Tests, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 116
Table 50: Immunochemistry Rapid Tests, Argentina, Revenue ($m) USD Constant, by Sub-
Table 51: Immunochemistry Rapid Tests, Argentina, Revenue ($m) USD Constant, by Sub-
Table 52: Therapeutic Drug Monitoring, Argentina, Revenue ($m) USD Constant, by Sub-
Table 53: Therapeutic Drug Monitoring, Argentina, Revenue ($m) USD Constant, by Sub-
Table 54: Immunochemistry Analyzers, Argentina, Revenue ($m) USD Constant, by Sub-
Table 55: Immunochemistry Analyzers, Argentina, Revenue ($m) USD Constant, by Sub-
Table 56: Immuno Chemistry, Argentina, Distribution Share by Revenue ($m), USD Constant,
2010-2011 129
Table 57: Immuno Chemistry, Argentina, Company Share by Revenue ($m), USD Constant, 2010-
2011 131
Table 58: Infectious Immunology Market, Argentina, Segment Contribution (%), 2011 134
Table 59: Infectious Immunology, Argentina, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 136
Table 60: Infectious Immunology, Argentina, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 138
Table 61: Infectious Immunology Rapid Tests, Argentina, Revenue ($m) USD Constant, by Sub-

Table 62: Infectious Immunology Rapid Tests, Argentina, Revenue ($m) USD Constant, by Sub-
Table 63: Infectious Immunology, Argentina, Distribution Share by Revenue ($m), USD Constant,
2010-2011 143
Table 64: Infectious Immunology, Argentina, Company Share by Revenue ($m), USD Constant,
2010-2011 145
Table 65: Microbiology Culture Market, Argentina, Segment Contribution (%), 2011 148
Table 66: Microbiology Culture, Argentina, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 150
Table 67: Microbiology Culture, Argentina, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 152
Table 68: Microbiology Analyzers, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 154
Table 69: Microbiology Analyzers, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 156
Table 70: Microbiology Culture, Argentina, Distribution Share by Revenue ($m), USD Constant,
2010-2011 157
Table 71: Microbiology Culture, Argentina, Company Share by Revenue ($m), USD Constant,
2010-2011 159
Table 72: Clinical Chemisty Market Pipeline Products 173
Table 73: Immuno Chemistry Market Pipeline Products 176
Table 74: Haematology Market Pipeline Products 187
Table 75: Infectious Immunology Market Pipeline Products 189
Table 76: Microbiology Culture Market Pipeline Products 196
Table 77: Histology And Cytology Market Pipeline Products 197
Table 78: Genetic Testing Market Pipeline Products 198
Table 79: bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 203
Table 80: Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For
Archimedes Particle Metrology System 205
Table 81: Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ 206
Table 82: BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology
Assays 207
Table 83: CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital
Microscopy Hematology Solutions 208
Table 84: Med BioGene Amends Licensing Agreement With Precision Therapeutics For
LungExpress Dx Test 210
Table 85: Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon
Biotechnology 212
Table 86: CML HealthCare Enters Into Agreement With MaRS Innovation 213
Table 87: Castle Biosciences Enters Into Licensing Agreement With Brigham and Women''s
Hospital For Mesothelioma Test 214
Table 88: Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein

Array Products 215
Table 89: GeneCentric Diagnostics Enters Into Licensing Agreement With University of North
Carolina 216
Table 90: Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium
TB Test 217
Table 91: SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For
PhenoFluor 218
Table 92: Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 219
Table 93: MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
220
Table 94: NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
222
Table 95: Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis 223
Table 96: Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4
POC Test 224
Table 97: One Lambda Enters Into Co-Marketing Agreement With CellTrend 225
Table 98: Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For
ALK Cancer Biomarker 226
Table 99: Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 227
Table 100: Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG
Marker 228
Table 101: Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor
Cell Technology 229
Table 102: Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA 230
Table 103: Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For
LongRange PCR Kit 231
Table 104: Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 232
Table 105: Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For
Pressure Cycling Technology 233
Table 106: LipoScience Enters Into Licensing Agreement With Cleveland Clinic 234
Table 107: GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact
Cyclotron And PET Tracer System 235
Table 108: Sysmex Extends Distribution Agreement With Roche 236
Table 109: NexDx Enters Into Licensing Agreement With University of California For Epigenetic
Biomarkers 237
Table 110: Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 238

1.2 List of Figures
Figure 1: In Vitro Diagnostics, Market Segmentation 16
Figure 2: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Constant, 2004-2018 17
Figure 3: In Vitro Diagnostics Market, Argentina, Revenue Mix ($m), 2011 19
Figure 4: In Vitro Diagnostics Market, Argentina, Category Contribution (%), 2011 20

Figure 5: In Vitro Diagnostics Market, Argentina, Cross-Category Analysis, 2004-2018 22
Figure 6: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 24
Figure 7: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 26
Figure 8: In Vitro Diagnostics, Argentina, Company Share (%), 2011 28
Figure 9: Clinical Chemistry, Market Segmentation 30
Figure 10: Clinical Chemistry Market, Argentina, Revenue Mix ($m), 2011 31
Figure 11: Clinical Chemistry Market, Argentina, Segment Contribution (%), 2011 32
Figure 12: Clinical Chemistry, Argentina, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 33
Figure 13: Clinical Chemistry, Argentina, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 35
Figure 14: Clinical Chemisty Analyzers, Argentina, Revenue ($m) USD Constant, by Sub-
Figure 15: Clinical Chemisty Analyzers, Argentina, Revenue ($m) USD Constant, by Sub-
Figure 16: Urine Analysis, Argentina, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 41
Figure 17: Urine Analysis, Argentina, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 43
Figure 18: Clinical Chemistry, Argentina, Company Share (%), 2011 46
Figure 19: Genetic Testing, Market Segmentation 48
Figure 20: Genetic Testing Market, Argentina, Revenue Mix ($m), 2011 49
Figure 21: Genetic Testing Market, Argentina, Segment Contribution (%), 2011 50
Figure 22: Genetic Testing, Argentina, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 51
Figure 23: Genetic Testing, Argentina, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 53
Figure 24: Genetic Testing, Argentina, Company Share (%), 2011 56
Figure 25: Haematology Market, Market Segmentation 58
Figure 26: Haematology Market, Argentina, Revenue Mix ($m), 2011 59
Figure 27: Haematology Market, Argentina, Segment Contribution (%), 2011 60
Figure 28: Haematology, Argentina, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 61
Figure 29: Haematology, Argentina, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 63
Figure 30: Haematology Reagents, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 65
Figure 31: Haematology Reagents, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 67
Figure 32: Immunohaematology, Argentina, Revenue ($m) USD Constant, by Sub-Segment,

Historic, 2004-2011 69
Figure 33: Immunohaematology, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 71
Figure 34: Haemostasis, Argentina, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 73
Figure 35: Haemostasis, Argentina, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 75
Figure 36: Haematology Rapid Tests, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 77
Figure 37: Haematology Rapid Tests, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 79
Figure 38: Haematology Cell Counters, Argentina, Revenue ($m) USD Constant, by Sub-
Figure 39: Haematology Cell Counters, Argentina, Revenue ($m) USD Constant, by Sub-
Figure 40: Haematology, Argentina, Company Share (%), 2011 86
Figure 41: Histology and Cytology Market, Market Segmentation 88
Figure 42: Histology And Cytology Market, Argentina, Revenue Mix ($m), 2011 89
Figure 43: Histology And Cytology Market, Argentina, Segment Contribution (%), 2011 90
Figure 44: Histology And Cytology, Argentina, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 91
Figure 45: Histology And Cytology, Argentina, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 93
Figure 46: Histology And Cytology, Argentina, Company Share (%), 2011 96
Figure 47: Immuno Chemistry Market, Argentina, Revenue Mix ($m), 2011 98
Figure 48: Immuno Chemistry Market, Argentina, Segment Contribution (%), 2011 99
Figure 49: Immuno Chemistry, Argentina, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 101
Figure 50: Immuno Chemistry, Argentina, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 103
Figure 51: Disease Specific Immunochemistry, Argentina, Revenue ($m) USD Constant, by Sub-
Figure 52: Disease Specific Immunochemistry, Argentina, Revenue ($m) USD Constant, by Sub-
Figure 53: Drugs of Abuse / Toxicology, Argentina, Revenue ($m) USD Constant, by Sub-
Figure 54: Drugs of Abuse / Toxicology, Argentina, Revenue ($m) USD Constant, by Sub-
Figure 55: Endocrinology Tests, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 113
Figure 56: Endocrinology Tests, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 115

Figure 57: Immunochemistry Rapid Tests, Argentina, Revenue ($m) USD Constant, by Sub-
Figure 58: Immunochemistry Rapid Tests, Argentina, Revenue ($m) USD Constant, by Sub-
Figure 59: Therapeutic Drug Monitoring, Argentina, Revenue ($m) USD Constant, by Sub-
Figure 60: Therapeutic Drug Monitoring, Argentina, Revenue ($m) USD Constant, by Sub-
Figure 61: Immunochemistry Analyzers, Argentina, Revenue ($m) USD Constant, by Sub-
Figure 62: Immunochemistry Analyzers, Argentina, Revenue ($m) USD Constant, by Sub-
Figure 63: Immuno Chemistry, Argentina, Company Share (%), 2011 130
Figure 64: Infectious Immunology, Market Segmentation 132
Figure 65: Infectious Immunology Market, Argentina, Revenue Mix ($m), 2011 133
Figure 66: Infectious Immunology Market, Argentina, Segment Contribution (%), 2011 134
Figure 67: Infectious Immunology, Argentina, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 135
Figure 68: Infectious Immunology, Argentina, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 137
Figure 69: Infectious Immunology Rapid Tests, Argentina, Revenue ($m) USD Constant, by Sub-
Figure 70: Infectious Immunology Rapid Tests, Argentina, Revenue ($m) USD Constant, by Sub-
Figure 71: Infectious Immunology, Argentina, Company Share (%), 2011 144
Figure 72: Microbiology Culture, Market Segmentation 146
Figure 73: Microbiology Culture Market, Argentina, Revenue Mix ($m), 2011 147
Figure 74: Microbiology Culture Market, Argentina, Segment Contribution (%), 2011 148
Figure 75: Microbiology Culture, Argentina, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 149
Figure 76: Microbiology Culture, Argentina, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 151
Figure 77: Microbiology Analyzers, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 153
Figure 78: Microbiology Analyzers, Argentina, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 155
Figure 79: Microbiology Culture, Argentina, Company Share (%), 2011 158
Figure 80: F. Hoffmann-La Roche Ltd., Company Share (%),Argentina In Vitro Diagnostics Market,
2011 160
Figure 81: Siemens Healthcare, Company Share (%),Argentina In Vitro Diagnostics Market, 2011
161
Figure 82: Abbott Laboratories, Company Share (%),Argentina In Vitro Diagnostics Market, 2011

162
Figure 83: Ortho-Clinical Diagnostics Inc., Company Share (%),Argentina In Vitro Diagnostics
Market, 2011 163
Figure 84: Beckman Coulter, Inc., Company Share (%),Argentina In Vitro Diagnostics Market,
2011 164
Figure 85: Alere Inc., Company Share (%),Argentina In Vitro Diagnostics Market, 2011 165
Contact: sales@reportsandreports.com for more information.

Argentina In Vitro Diagnostics Market Outlook

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Viewers also liked

Viewers also liked (14)

Similar to Argentina In Vitro Diagnostics Market Outlook

Similar to Argentina In Vitro Diagnostics Market Outlook (18)

Argentina In Vitro Diagnostics Market Outlook